Abstract:Objective: The escalating challenge posed by multidrug-resistant tuberculosis (MDR-TB) necessitates the discovery of potent treatment agents. This study aims to synthesize, characterize, and evaluate the antitubercular potential of 33 novel 2,3-(4-aminobenzamido)benzoic acid derivatives ( 1–33 ). Methods: The synthesis involved a three-stage reaction series starting with p -aminobenzoic acid treated with concentrated hydrochloric acid to obtain its salt. This was further modified to ammonium benzoyl chloride using thionyl chloride. The ammonium benzoyl chloride was then condensed with 2 or 3 benzoic acids to yield the desired 2,3-(4-aminobenzamido)benzoic acid derivatives. The structures of these compounds were elucidated using FT-IR, HR-MS, 1 H, and 13 C NMR. Their antituberculosis activity was assessed using the Alamar blue dye assay against Mycobacterium tuberculosis H37RV. Results and Discussion: Out of the 33 synthesized compounds, 12 showed sensitivity to Mycobacterium tuberculosis (MTB). Notably, five compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) demonstrated significant potency, with minimal inhibitory concentrations (MICs) of 1.6 μg/mL, nearly 50 times lower than the standard drug. These results strongly suggest the potential of these compounds as effective tuberculosis therapeutics. Conclusions: The synthesized series of 2,3-(4-aminobenzamido)benzoic acid derivatives have shown promising antituberculosis activity. Specifically, compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) exhibited noteworthy potency. It is crucial that future research focuses on further screening the active compounds ( 2 – 4 ), ( 10 ), ( 14 ), ( 18 ), ( 19 ), ( 21 ), ( 26 ), ( 28 ), ( 30 ), and ( 33 ) for antimicrobial strains and evaluating compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) using the DHFR enzyme-specific assay to advance the development of effective tuberculosis treatments.

Synthesis and Biological Evaluation of Novel Benzhydrylpiperazine-Coupled Nitrobenzenesulfonamide Hybrids

Targeted Hybridization: Pyrazine‐2‐Carbohydrazide Derivatives as Promising Antitubercular and Antimicrobial Leads

Design, Synthesis and Anti-Mycobacterial Activity Evaluation of Benzofuran-Isatin Hybrids.

Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis

Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Synthesis and Evaluation of (S,S)-N,N '-Bis-[3-(2,2 ',6,6 '-Tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) Analogs with Anti-Tuberculosis Activity

Design, synthesis, characterization, and biological evaluation of novel pyrazine-1,3,4-oxadiazole/[1,2,4] triazolo[3,4-b][1,3,4]thiadiazine hybrids as potent antimycobacterial agents

Synthesis, Antitubercular Evaluation of New 2,3-(4-Aminobenzamido)benzoic Acid Derivatives

Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities.

Isoniazid Hybrids As Potential Antitubercular Agents

Synthesis and Anti-Mycobacterium Activity of Some New N-Rich Heterocyclic Derivatives and Their Molecular Docking, and DFT Studies

Identification of coumarin - benzimidazole hybrids as potential antibacterial agents: Synthesis, in vitro and in vivo biological assessment, and ADMET prediction

New Synergistic Benzoquinone Scaffolds as Inhibitors of Mycobacterial Cytochrome bc1 Complex to Treat Multi-Drug Resistant Tuberculosis

Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles

Synthesis and antibacterial evaluation of new naphthalimide-coumarin hybrids against multidrug-resistant S. aureus and M. tuberculosis

N‐Substituted piperazine‐coupled imidazo[2,1‐b]thiazoles as inhibitors of Mycobacterium tuberculosis: Synthesis, evaluation, and docking studies

Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial, antifungal and antitubercular agents

Antitubercular evaluation of dihydropyridine-triazole conjugates: design, synthesis, in vitro screening, SAR and in silico ADME predictions

Design, synthesis, and anti-mycobacterial evaluation of 1,8-naphthyridine-3-carbonitrile analogues